Novartis Investigative Site

Santa Cruz, Santa Cruz de Tenerife 38009

1 studies enrolling now · 2 studies all time

What they study most

Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Relapsing Multiple Sclerosis

Studies at this site

• Asciminib Roll-over Study — Recruiting now
• An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab — Completed